LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 23

Search options

  1. Article ; Online: Maintenance avelumab in metastatic bladder cancer as a step towards sequencing immunotherapy.

    Samaha, Hady / Samaha, Ramy / Sarkis, Julien / Kattan, Joseph

    Immunotherapy

    2021  Volume 13, Issue 4, Page(s) 271–275

    MeSH term(s) Antibodies, Monoclonal, Humanized/therapeutic use ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy ; Maintenance Chemotherapy ; Progression-Free Survival ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
    Chemical Substances Antibodies, Monoclonal, Humanized ; Immune Checkpoint Inhibitors ; avelumab (KXG2PJ551I)
    Language English
    Publishing date 2021-01-05
    Publishing country England
    Document type Editorial
    ZDB-ID 2495964-9
    ISSN 1750-7448 ; 1750-743X
    ISSN (online) 1750-7448
    ISSN 1750-743X
    DOI 10.2217/imt-2020-0261
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Calcification of the ascending aorta, left heart valves and coronaries: associated diseases and a new classification.

    Samaha, Hady / Chalhoub, Najib / Tabet, Margherita / Smayra, Tarek / Sleilaty, Ghassan

    Future cardiology

    2022  Volume 18, Issue 9, Page(s) 687–695

    Abstract: Aim: ...

    Abstract Aim:
    MeSH term(s) Aorta ; Aorta, Thoracic ; Calcinosis/diagnostic imaging ; Heart Valves ; Humans ; Tomography, X-Ray Computed ; Vascular Calcification/complications ; Vascular Calcification/diagnostic imaging
    Language English
    Publishing date 2022-07-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 2274267-0
    ISSN 1744-8298 ; 1479-6678
    ISSN (online) 1744-8298
    ISSN 1479-6678
    DOI 10.2217/fca-2022-0016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Right posterior insular epidural stimulation in rats with neuropathic pain induces a frequency-dependent and opioid system-mediated reduction of pain and its comorbid anxiety and depression.

    Mehsein, Zeinab / Kobaïter-Maarrawi, Sandra / Samaha, Hady / El Shami, Mohamad / Albeaini, Sylvana / Maarrawi, Joseph

    Progress in neuro-psychopharmacology & biological psychiatry

    2023  Volume 128, Page(s) 110845

    Abstract: Neuropathic pain (NP) is a sensory, emotional, and persistent disturbing experience caused by a lesion or disease of the somatosensory system which can lead when chronic to comorbidities such as anxiety and depression. Available treatments ( ... ...

    Abstract Neuropathic pain (NP) is a sensory, emotional, and persistent disturbing experience caused by a lesion or disease of the somatosensory system which can lead when chronic to comorbidities such as anxiety and depression. Available treatments (pharmacotherapy, neurostimulation) have partial and unpredictable response; therefore, it seems necessary to find a new therapeutical approach that could alleviate most related symptoms and improve patients 'emotional state'. Posterior Insula seems to be a potential target of neurostimulation for pain relief. However, its effects on pain-related anxiety and depression remain unknown. Using rats with spared nerve injury (SNI), this study aims to elucidate the correlation between NP and anxio-depressive disorders, evaluate potential analgesic, anxiolytic, and antidepressant effects of right posterior insula stimulation (IS) using low (LF-IS, 50 Hz) or high (HF-IS, 150 Hz) frequency and assess endogenous opioid involvement in these effects. Results showed positive correlation between NP, anxiety, and depression. LF-IS reversed anhedonia and despair-like behavior through pain alleviation, whereas HF-IS only reduced anhedonia, all effects involving endogenous opioids. These findings support the link between NP and anxio-depressive disorders. Moreover, IS appears to have analgesic, anxiolytic and antidepressant effects mediated by the endogenous opioid system, making it a promising target for neurostimulation.
    Language English
    Publishing date 2023-08-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 781181-0
    ISSN 1878-4216 ; 0278-5846
    ISSN (online) 1878-4216
    ISSN 0278-5846
    DOI 10.1016/j.pnpbp.2023.110845
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV.

    Losada, Cecilia / Samaha, Hady / Scherer, Erin M / Kazzi, Bahaa / Khalil, Lana / Ofotokun, Ighovwerha / Rouphael, Nadine

    Vaccines

    2023  Volume 11, Issue 6

    Abstract: People living with HIV (PLH) experience higher rates of HPV infection as well as an increased risk of HPV-related disease, including malignancies. Although they are considered a high-priority group for HPV vaccination, there are limited data regarding ... ...

    Abstract People living with HIV (PLH) experience higher rates of HPV infection as well as an increased risk of HPV-related disease, including malignancies. Although they are considered a high-priority group for HPV vaccination, there are limited data regarding the long-term immunogenicity and efficacy of HPV vaccines in this population. Seroconversion rates and geometric mean titers elicited by vaccination are lower in PLH compared to immunocompetent participants, especially in individuals with CD4 counts below 200 cells/mm
    Language English
    Publishing date 2023-06-05
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines11061067
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care?

    Radi, Imad / Samaha, Ramy / El Hajj, Joanna / Samaha, Hady / Kourie, Hampig Raphael

    Future oncology (London, England)

    2020  Volume 17, Issue 3, Page(s) 229–233

    MeSH term(s) Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Chemotherapy, Adjuvant ; Humans ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/surgery ; Perioperative Period ; Standard of Care ; Treatment Outcome
    Chemical Substances Antineoplastic Agents ; Biomarkers, Tumor
    Language English
    Publishing date 2020-12-11
    Publishing country England
    Document type Editorial
    ZDB-ID 2274956-1
    ISSN 1744-8301 ; 1479-6694
    ISSN (online) 1744-8301
    ISSN 1479-6694
    DOI 10.2217/fon-2020-0836
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans.

    Grigoryan, Lilit / Feng, Yupeng / Bellusci, Lorenza / Lai, Lilin / Wali, Bushra / Ellis, Madison / Yuan, Meng / Arunachalam, Prabhu S / Hu, Mengyun / Kowli, Sangeeta / Gupta, Sheena / Maysel-Auslender, Sofia / Maecker, Holden T / Samaha, Hady / Rouphael, Nadine / Wilson, Ian A / Moreno, Alberto C / Suthar, Mehul S / Khurana, Surender /
    Pillet, Stéphane / Charland, Nathalie / Ward, Brian J / Pulendran, Bali

    Science immunology

    2024  Volume 9, Issue 94, Page(s) eadi8039

    Abstract: Vaccine adjuvants increase the breadth of serum antibody responses, but whether this is due to the generation of antigen-specific B cell clones with distinct specificities or the maturation of memory B cell clones that produce broadly cross-reactive ... ...

    Abstract Vaccine adjuvants increase the breadth of serum antibody responses, but whether this is due to the generation of antigen-specific B cell clones with distinct specificities or the maturation of memory B cell clones that produce broadly cross-reactive antibodies is unknown. Here, we longitudinally analyzed immune responses in healthy adults after two-dose vaccination with either a virus-like particle COVID-19 vaccine (CoVLP), CoVLP adjuvanted with AS03 (CoVLP+AS03), or a messenger RNA vaccination (mRNA-1273). CoVLP+AS03 enhanced the magnitude and durability of circulating antibodies and antigen-specific CD4
    MeSH term(s) Adult ; Humans ; Influenza Vaccines ; Memory B Cells ; COVID-19 Vaccines ; Influenza, Human ; Antibodies, Viral ; COVID-19/prevention & control ; Drug Combinations ; Polysorbates ; Squalene ; alpha-Tocopherol
    Chemical Substances AS03 adjuvant (A7YT618XBV) ; Influenza Vaccines ; COVID-19 Vaccines ; Antibodies, Viral ; Drug Combinations ; Polysorbates ; Squalene (7QWM220FJH) ; alpha-Tocopherol (H4N855PNZ1)
    Language English
    Publishing date 2024-04-05
    Publishing country United States
    Document type Journal Article
    ISSN 2470-9468
    ISSN (online) 2470-9468
    DOI 10.1126/sciimmunol.adi8039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipients.

    Thompson, Elizabeth A / Ngecu, Wabathi / Stoddart, Laila / Johnston, Trevor S / Chang, Amy / Cascino, Katherine / Alejo, Jennifer L / Abedon, Aura T / Samaha, Hady / Rouphael, Nadine / Tobian, Aaron Ar / Segev, Dorry L / Werbel, William A / Karaba, Andrew H / Blankson, Joel N / Cox, Andrea L

    JCI insight

    2023  Volume 8, Issue 10

    Abstract: BackgroundThe SARS-CoV-2 Omicron BA.5 subvariant escapes vaccination-induced neutralizing antibodies because of mutations in the spike (S) protein. Solid organ transplant recipients (SOTRs) develop high COVID-19 morbidity and poor Omicron variant ... ...

    Abstract BackgroundThe SARS-CoV-2 Omicron BA.5 subvariant escapes vaccination-induced neutralizing antibodies because of mutations in the spike (S) protein. Solid organ transplant recipients (SOTRs) develop high COVID-19 morbidity and poor Omicron variant recognition after COVID-19 vaccination. T cell responses may provide a second line of defense. Therefore, understanding which vaccine regimens induce robust, conserved T cell responses is critical.MethodsWe evaluated anti-S IgG titers, subvariant pseudo-neutralization, and S-specific CD4+ and CD8+ T cell responses from SOTRs in a national, prospective, observational trial (n = 75). Participants were selected if they received 3 doses of mRNA (homologous boosting) or 2 doses of mRNA followed by Ad26.COV2.S (heterologous boosting).ResultsHomologous boosting with 3 mRNA doses induced the highest anti-S IgG titers. However, antibodies induced by both vaccine regimens demonstrated lower pseudo-neutralization against BA.5 compared with the ancestral strain. In contrast, vaccine-induced S-specific T cells maintained cross-reactivity against BA.5 compared with ancestral recognition. Homologous boosting induced higher frequencies of activated polyfunctional CD4+ T cell responses, with polyfunctional IL-21+ peripheral T follicular helper cells increased in mRNA-1273 compared with BNT162b2. IL-21+ cells correlated with antibody titers. Heterologous boosting with Ad26.COV2.S did not increase CD8+ responses compared to homologous boosting.ConclusionBoosting with the ancestral strain can induce cross-reactive T cell responses against emerging variants in SOTRs, but alternative vaccine strategies are required to induce robust CD8+ T cell responses.FundingBen-Dov Family; NIH National Institute of Allergy and Infectious Diseases (NIAID) K24AI144954, NIAID K08AI156021, NIAID K23AI157893, NIAID U01AI138897, National Institute of Diabetes and Digestive and Kidney Diseases T32DK007713, and National Cancer Institute 1U54CA260492; Johns Hopkins Vice Dean of Research Support for COVID-19 Research in Immunopathogenesis; and Emory COVID-19 research repository.
    MeSH term(s) Humans ; Transplant Recipients ; Ad26COVS1 ; BNT162 Vaccine ; COVID-19 Vaccines ; Prospective Studies ; COVID-19/prevention & control ; SARS-CoV-2 ; Antibodies, Neutralizing ; Immunoglobulin G
    Chemical Substances Ad26COVS1 (JT2NS6183B) ; BNT162 Vaccine ; COVID-19 Vaccines ; Antibodies, Neutralizing ; Immunoglobulin G
    Language English
    Publishing date 2023-05-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.168470
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Durability of immune responses to mRNA booster vaccination against COVID-19.

    Arunachalam, Prabhu S / Lai, Lilin / Samaha, Hady / Feng, Yupeng / Hu, Mengyun / Hui, Harold Sai-Yin / Wali, Bushra / Ellis, Madison / Davis-Gardner, Meredith E / Huerta, Christopher / Bechnak, Kareem / Bechnak, Sarah / Lee, Matthew / Litvack, Matthew B / Losada, Cecilia / Grifoni, Alba / Sette, Alessandro / Zarnitsyna, Veronika I / Rouphael, Nadine /
    Suthar, Mehul S / Pulendran, Bali

    The Journal of clinical investigation

    2023  Volume 133, Issue 10

    Abstract: BackgroundMaintaining durable immunity following vaccination represents a major challenge, but whether mRNA booster vaccination improves durability is unknown.MethodsWe measured antibody responses in 55 healthy adults, who received a booster dose of the ... ...

    Abstract BackgroundMaintaining durable immunity following vaccination represents a major challenge, but whether mRNA booster vaccination improves durability is unknown.MethodsWe measured antibody responses in 55 healthy adults, who received a booster dose of the Pfizer-BioNTech or Moderna vaccine against SARS-CoV-2 and calculated the half-life of the antibody titers. We also measured memory B and T cell responses in a subset of 28 participants. In 13 volunteers who received a second booster vaccine, we measured serum antibody titers and memory B and T cell responses.ResultsThe booster (third immunization) dose at 6 to 10 months increased the half-life of the serum-neutralizing antibody (nAb) titers to 76 days from 56 to 66 days after the primary 2-dose vaccination. A second booster dose (fourth immunization) a year after the primary vaccination further increased the half-life to 88 days. However, despite this modestly improved durability in nAb responses against the ancestral (WA.1) strain, there was a loss of neutralization capacity against the Omicron subvariants BA.2.75.2, BQ.1.1, and XBB.1.5 (48-, 71-, and 66-fold drop in titers, respectively, relative to the WA.1 strain). Although only 45% to 65% of participants demonstrated a detectable nAb titer against the newer variants after the booster (third dose), the response declined to below the detection limit in almost all individuals by 6 months. In contrast, booster vaccination induced antigen-specific memory B and T cells that persisted for at least 6 months.ConclusionThe durability of serum antibody responses improves only marginally following booster immunizations with the Pfizer-BioNTech or Moderna mRNA vaccines.
    MeSH term(s) Adult ; Humans ; COVID-19/prevention & control ; SARS-CoV-2 ; COVID-19 Vaccines ; Vaccination ; RNA, Messenger ; Immunity ; Antibodies, Viral ; Antibodies, Neutralizing
    Chemical Substances COVID-19 Vaccines ; RNA, Messenger ; Antibodies, Viral ; Antibodies, Neutralizing
    Language English
    Publishing date 2023-05-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI167955
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1.

    Davis-Gardner, Meredith E / Lai, Lilin / Wali, Bushra / Samaha, Hady / Solis, Daniel / Lee, Matthew / Porter-Morrison, Andrea / Hentenaar, Ian Thomas / Yamamoto, Fumiko / Godbole, Sucheta / Douek, Daniel C / Lee, Frances Eun-Hyung / Rouphael, Nadine / Moreno, Alberto / Pinsky, Benjamin A / Suthar, Mehul S

    bioRxiv : the preprint server for biology

    2022  

    Abstract: The emergence of the highly divergent SARS-CoV-2 Omicron variant has jeopardized the efficacy of vaccines based on the ancestral spike. The bivalent COVID-19 mRNA booster vaccine within the United States is comprised of the ancestral and the Omicron BA.5 ...

    Abstract The emergence of the highly divergent SARS-CoV-2 Omicron variant has jeopardized the efficacy of vaccines based on the ancestral spike. The bivalent COVID-19 mRNA booster vaccine within the United States is comprised of the ancestral and the Omicron BA.5 spike. Since its approval and distribution, additional Omicron subvariants have been identified with key mutations within the spike protein receptor binding domain that are predicted to escape vaccine sera. Of particular concern is the R346T mutation which has arisen in multiple subvariants, including BA.2.75.2 and BQ.1.1. Using a live virus neutralization assay, we evaluated serum samples from individuals who had received either one or two monovalent boosters or the bivalent booster to determine neutralizing activity against wild-type (WA1/2020) virus and Omicron subvariants BA.1, BA.5, BA.2.75.2, and BQ.1.1. In the one monovalent booster cohort, relative to WA1/2020, we observed a reduction in neutralization titers of 9-15-fold against BA.1 and BA.5 and 28-39-fold against BA.2.75.2 and BQ.1.1. In the BA.5-containing bivalent booster cohort, the neutralizing activity improved against all the Omicron subvariants. Relative to WA1/2020, we observed a reduction in neutralization titers of 3.7- and 4-fold against BA.1 and BA.5, respectively, and 11.5- and 21-fold against BA.2.75.2 and BQ.1.1, respectively. These data suggest that the bivalent mRNA booster vaccine broadens humoral immunity against the Omicron subvariants.
    Language English
    Publishing date 2022-11-01
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2022.10.31.514636
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.

    Davis-Gardner, Meredith E / Lai, Lilin / Wali, Bushra / Samaha, Hady / Solis, Daniel / Lee, Matthew / Porter-Morrison, Andrea / Hentenaar, Ian T / Yamamoto, Fumiko / Godbole, Sucheta / Liu, Yuan / Douek, Daniel C / Lee, Frances Eun-Hyung / Rouphael, Nadine / Moreno, Alberto / Pinsky, Benjamin A / Suthar, Mehul S

    The New England journal of medicine

    2022  Volume 388, Issue 2, Page(s) 183–185

    Language English
    Publishing date 2022-12-21
    Publishing country United States
    Document type Letter ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2214293
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top